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HUMORAL IMMUNOSTIMULATION
IV . Role of Complement*
BY WILLIAM T . SHEARER, JOHN P. ATKINSON, MICHAEL M . FRANK, AND
CHARLES W . PARKER
(From The Departments ofPediatrics and Medicine, Washington University School ofMedicine, St .
Louis, Missouri 63110 and the Laboratory of Clinical Investigation, National Institute ofAllergy and
Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014)
Previous studies in our laboratory have demonstrated that, under appropriate
conditions, in vitro tumor cell growth and metabolism are stimulated by
antitumor antibodies as evidenced by increased cellular incorporation of radioac-
tive nucleosides (references 1-3, and footnote 1 and 2), DNA synthesis," 2 and
cell growth (reference 4 and footnote 1) . Stimulation was obtained following
exposure of 2,4, 6-trinitrophenyl (TNP)-substituted HeLa, HEp-2, andL cells to
highly purified anti-TNP rabbit antibody or HeLa, HEp-2, L, and MOPC-315
cell lines to their respective whole-cell rabbit antibodies or isolated IgGfractions
(references 4 and 5, and footnotes 1 and 2) . The effect of antibody was dose de-
pendent with high concentrations inhibiting cell growth and lower concentrations
stimulating cell growth (reference 4 and footnote 1) . On the basis of these
observations we suggested that part of the enhancing effect of antibodies on
tumor cell growth in vivo might involve a direct stimulatory effect of the
antibody on tumor cell metabolism . Since complement (C) is present in vivo and
our earlier in vitro studies had been performed with heat-inactivated serum, it
became important to investigate the influence of C on the phenomenon . In the
present study we will present evidence that C greatly augments immunostimula-
tion in vitro with utilization of both classical and alternate pathways through C3 .
A preliminary report of this work has appeared (6) .
Materials and Methods
Cell Line .
￿
Mouse L cells (7), obtained from Grand Island Biological Corp ., Grand Island, N . Y .,
were used throughout . The cells were maintained in plastic T flasks (Falcon Plastics, Div . of
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BioQuest, Oxnard, Calif.) in a nutrient medium (NM)' containing Eagle's minimum essential
medium with glutamine plus 10% fetal calfserum (FCS) . NM prepared with heat-inactivated (56°C
for 30 min) FCS (hNM) was used in some experiments. A 5% CO,-humidified air atmosphere at 37°C
wasused for cell incubation . Difco trypsin (1 :250 ; Difco Laboratories, Detroit, Mich .) whichhasbeen
shown to possess 740 benzoyl-L-arginine ethyl esterU/mg ofenzyme' wasused to harvest the cells (see
below) .
Antiserum .
￿
Antiserum was raised in rabbits by immunization with an L cell-complete Freunds
adjuvant emulsion as previously described (reference 4 and footnote 1) . The animals received 2 x 10 ,
cells on three occasions each 2 wk apart. The first two injections of cells were in complete Freund's
adjuvant ; the last injection of cells was in 0.01M phosphate, pH 7.4, 0.15M NaCl (PBS) . Control
rabbit serum (CR) was obtained by injection of complete Fruend's adjuvant alone (reference 4 and
footnote 1) . Naive rabbit serum (animals unimmunized) was used for some experiments . Sera were
obtained at various times after initial immunization . As a rule, they were heat inactivated at 56°C for
30 min . All sera were sterile filtered .
Reaction of Cells with Antibody .
￿
Logarithmically growing L-cell monolayers were washed with
Ca++, Mg++-free Hanks' balanced salt solution, exposed to 0.05% trypsin for 3-5 min, scraped off the
Tflask, washed with either NM or hNM, pipetted into single cell suspensions, and plated in 1-ml vol
in 12 x75 mm plastic tissue culture tubes (Falcon Plastics, Div . of BioQuest) at a cell density of 5 x
10`/ml . Small volumes ofPBS alone or PBS containing varyingamountsofserums were added to the
cells .
Sources of C .
￿
Purified individual C components were obtained from Cordis Laboratories,Miami,
Fla. Normal sera containing C were obtained from fetal calves, noninbred, National Institutes of
Health multipurpose guinea pigs (NGPS), humans (NHS), BALB/C mice (NMS), andNewZealand
white rabbits (NRS) . C-deficient serums were obtained from guinea pigs congenitally deficient in the
fourth component (C4D) (8, 9), guinea pigs depleted of the third through ninth C components
[(C3-C9)D] (10), human serum congenitally deficient in CIr (GIRD) (11), a human congenitally
deficient in C2 (C2D) (12), ahuman with hereditary angioedema which hadno detectable C2 and less
than 0.5% normal level of C4 (C2,4D) (13), a human congenitally deficient in C5 (C5DHS) (14), mice
congenitally deficient in C5 (C5DMS) (15), and rabbits congenitally deficient in C6 (C6DRS) (16) .
Assay of C Activity and C Components .
￿
The methods for the preparation of C reagents and
methods for the hemolytic titration of CH .., C1, C2, C5, and C3-C9 complex have been previously
described (9, 17-20) . Partially purified C proteins were either prepared in our laboratory by standard
techniques (8, 9) or obtained from Cordis Laboratories .
C4 hemolytic titrations were performed utilizing C4D (8, 9) . This serum contains an excess of allC
components except C4 . A detailed investigation of this new assay system has been published (21) .
Hemolytic activity of C6 was determined by a similar method in which the ability ofthe test serum to
reconstitute C activity to C6DRS was employed (22, 23) .
The preparation of guinea pigs depleted of the late-acting C components C3-C9 by cobra venom
factor (Cordis Laboratories) has been previously published (10) . 20 h after intravenous injection of 20
U of cobra venom factor/100 g the animals were sacrificed by exsanguination . The C3-C9 hemolytic
titer was determined on this serum, and, if the titer was less than 0.5% of normal, the serum was
subsequently employed in in vitro studies.
Immunostimulation Assay .
￿
Previous studies showed that the stimulation of cellular incorpora-
tion of radioactive nucleosides was maximal (up to 200-fold) 24-72 h after exposure to antibody
(reference 4 and footnote 1) . Virtually all of the radioactivity was in DNA .' This was true for
[methyl-eH]thymidine and for [1zs1]-5-iodo-2'-deoxyuridine ([12°I]UdR) . `IUdR (Amersham/Searle
Corp ., Arlington Heights, Ill ., original sp act 200-2,000 mCi/mmol) wasadded to the cells at 48 or 72 h
Abbreviations used in this paper: AL, anti-L-cell antiserum ; GIRD, human serum lacking Clr;
C2D, humanserumlackingC2 ; C2,4D, humanserum lacking C2 and C4 ; (C3-C9)D, guinea pigserum
lacking C3-C9 ; C4D, guinea pig serum lacking C4 ; C5DHS, human serum lacking C5 ; C5DMS,
mouse serum lackingC5 ; C6DRS, rabbit serum lackingC6; CR, control rabbit serum ; FCS, fetal calf
serum ; hNM, NM containing heat-inactivated FCS ; [12'I]UdR, 1251-labeled 5-iodo-2'-deoxyuridine;
NHS, normal human serum; NM, nutrient medium ; NMS, normal mouse serum ; NGPS, normal
guinea pig serum ; NRS, normal rabbit serum; PBS, 0.01 M phosphate, pH7.4, 0.15M NaCl ; PHA,
phytohemagglutinin ; RS, control rabbit serum and anti-L-cell antiserum; SR, stimulation ratio .738
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of incubation. 24 h later the cells were harvested and the residual cellular radioactivity was
determined (reference 4 and footnote 1) . The stimulation ratio (SR) was calculated by the mean
counts per minute of experimental cells divided by that of PBS control cells.
Consumption of Guinea Pig C4.
￿
Cells were trypsinized for 3-5 min as described above and plated
into 12 x 75-mm tissue culture tubes in 1 ml of hNM at a cell density of 8 x 10'/ml. PBS, CR, or
rabbit anti-L-cell antiserum (AL) was added in various final dilutions before the addition of NGPS
(0.25% vol/vol) . After incubation at 37°C for various time periods, the supernates were aspirated from
replicate centrifuged samples and stored at -80°C until assayed for guinea pig C4 levels.
Human C3 Fluorescence Microscopy.
￿
Cells were plated in hNM at a 5 x 10' cell density/ml and
incubated with PBS, CR (1 :2,000 final dilution), or rabbit anti-L-cell antiserum (AL) (1 :2,000 final
dilution) . 10 u1 of fresh human serum were added to all conditions (in 1 ml) and the cells were
incubated for 30 min at 37°C, washed three times, and cooled to 4°C. The cells were incubated with a
1:60 dilution of monospecific goat antihuman C3 (Hyland Div., Travenol Laboratories Inc., Costa
Mesa, Calif.) for 30 min at 4°C, washed, incubated with a 1 :60 dilution of rhodamine-conjugated
rabbit antigoat IgG antiserum (Cappel Laboratories, Inc., Downingtown, Pa.) for 30 min at 4°C,
washed, and examined with a Leitz Ortholux fluorescence microscope with an episcopic light attach-
ment (E. Leitz, Inc., Rockleigh, N. J.). All sera except the NHS were heat inactivated.
C-Mediated Cytotoxicity. Cells were prepared in single cell suspension and plated in 1 ml of
hNM at 2 x 10'/ml. Small volumes of PBS, CR (1 :10 final dilution), AL (1:10 final dilution), guinea
pig sera (10% vol/vol), and guinea pig C component C3 (100 U) were added to the appropriate tubes.
The cells were incubated at 37'C for 60 min, washed, plated in 1 ml of hNM containing ['2'I]UdR
(0.05 gCi/ml), incubated for 24 h, washed, and counted for residual gamma radioactivity.
Results
Studies in Heated and Unheated Sera .
￿
In the presence of unheated FCS and
high dilutions of antibody there was an increase in both the maximum
stimulation ratio and in the dilution of antiserum that produced a detectable
increase in uptake of [1251]UdR. Fig. 1 demonstrates this augmentation of
nucleoside incorporation into antibody-treated L cells when the FCS in the
medium was unheated (column B as compared with column A) . In more
concentrated antibody solutions (1 :20) inclusion of unheated FCS in the medium
lowered the stimulation ratio to below 1.0, indicating cell killing. The augmenta-
tion of both cytotoxicity and stimulation was especially dramatic in antisera
obtained late in the course of immunization (from unboosted animals) . Similar
C-dependent effects were seen with the Ig and IgG fractions isolated from the
antisera (data not shown) .
It seems likely that the cytotoxic effect obtained at high concentrations of
antibody in the presence of unheated FCS involved classical antibody C-depend-
ent telly lysis. The cytotoxic effect with antiserum was in marked contrast to
what was observed with an equivalent amount (1 :20 dilution) of naive or CR
where stimulation of nucleoside incorporation was obtained. This may be a
nutritional effect since the medium contains only 10% FCS and the addition of
5% rabbit serum raises the protein content of the medium considerably.
Alternately the stimulatory properties of the 1:20 dilution of naive or CR might
involve the nonspecific adherence of aggregated rabbit Ig on the cell surface with
activation of nucleoside incorporation . Whatever the explanation, nonspecific
nutritional effects can not explain the stimulation with anti-L-cell antibody since
stimulation of nucleoside incorporation occurred at antiserum dilutions up to
1:200,000 (Fig. 1 B, 2) . The only dilution of CR that produced astimulatory effect
at a greater than 1:20 dilution was found in 13,3 (Fig. 1). This may represent aW . T . SHEARER, J . P . ATKINSON, M . M . FRANK, C . W . PARKER
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FIG. 1 .
￿
Stimulation of nucleoside uptake in L cells treated with RS : Effects of fresh serum
and time after immunization . A column (vertical) : experiments with heat-inactivated
FCS(hFCS) in the medium . B column : experiments with FCS in the medium . Rows
(horizontal) 1, 2, 3, and4 indicate sera harvested2wk, and 2, 4, and8mo after immunization,
respectively . The dashed line indicates the RS obtained using antiserum 1 wk after boosting
the animals (8 mo after initial immunization) with L cells without adjuvant . Cells were
cultured in either hNM or NM in the presence of either PBS, CR (closed circles), orAL (open
circles) at the final dilutions indicated . All determinations were performed in triplicate ; PBS
controls had 300-600 cpm . Naive rabbit serum produced a stimulative effect at 1 :20 dilution
identical to CR .
natural antibody or a fortuitous, immunologic cross-reaction between cells and
Mycobacterium tuberculosis in the adjuvant .
If the factor in unheated FCS which enhances cytotoxicity is C then it should
be possible to show that unheated sera from other species can also promote the
response . In accord with this possibility when both the RS and the FCS in the
medium were heated the stimulatory effect of antibody was lost almost entirely
(even though some specific cytotoxicity remained as compared to CR) (Fig . 2 D) .
When the rabbit antibody was unheated and the FCS was heated the response
was partially restored (Fig . 2 B) indicating that the stimulating factor is present
in the rabbit serum as well as in the FCS . Moreover, as will be shown below,
NGPS, NMS, and NHS also possess this property .
Studies with Sera Deficient in C1, C4, C2, and C3-C9C Components .
￿
Guinea
pigC component C4 as well as the later components C3-C9 were found to be quite
important for augmentation of immunostimulation. In antiserum obtained late
after immunization almost no augmentation of immunostimulation was seen
with either the C4D or the (C3-C9)D (maximal stimulation ratios 4.96 and 2.37,740 HUMORAL IMMUNOSTIMULATION
respectively, as compared to 152 for NGPS at an antiserum dilution of 1 :200)
(Table 1) . With earlier antisera the response to (C3-C9)D was again essentially
absent butthe C4D was partially active provided high concentrations of antibody
were used (Table 11) . Thus, it appeared that not only was C important in the
stimulation by antibody but that both the alternate and classical pathways could
be utilized depending on the antiserum concentration and the experimental
conditions . Whether this is an effect of antibody concentration per se or the class
of antibody participating in the response remains to be elucidated .
SERUM DILUTION
FIG. 2.
￿
Stimulation of nucleoside uptake in L cells treated with RS harvested 8 mo after
immunization : Effects of fetal calf C and rabbit C. A, unheated FCS in the medium and
unheated rabbit sera (RS) ; B, heat-inactivated FCS and unheated rabbit sera; C, unheated
FCS and heat-inactivated rabbit sera ; and D, heat-inactivated FCSand rabbit sera .
TABLE I
Effect of Guinea Pig C4 and C3-C9 Upon Immunostimulation : Results with a Late Antiserum
of Low Titer
Cells were incubated in the presence of various final dilutions of CR or AL harvested 8 mo after immunization . Guinea pig
sera from animals described in the Materials and Methods were added, i .e ., 5 Atl to 1 ml : 0.5% . The results are expressed
3s the mean of triplicate determinations (cPM) t standard error of the mean (SE) .
Sera added tohNM . . . . . None NGPS C4D (C3-C9)D
Conditions cpm t SE SR cpm f SE SR cpm t SE SR cpm t SE SR
PBS 295 f 93 1.00 263 t 38 1.00 275 t 38 1.00 295 t 65 1.00
CR 1:200 258 f 42 0.87 588 t 263 2.24 228 f 38 0.83 251 t 40 0.85
CR 1:2,000 162 f 24 0.55 168 t 46 0.64 327 t 76 1.19 248 f 41 0.84
CR 1:20,000 192 38 0.65 151 f 19 0.57 271 f 28 0.99 175 t 48 0.59
AL 1:200 541 t 113 1.83 39,950 f 685 152 652 f 22 2.37 1,464 t 41 4.96
AL 1:2,000 384 f 103 0.78 37,567 t 177 143 570 t 4 2.07 478 t 58 1.62
AL 1:20,000 557 t 94 1.89 1,678 f 823 6.38 342 t 16 1.24 329 t 126 1.12W. T. SHEARER, J. P. ATKINSON, M. M. FRANK, C. W. PARKER
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Several human sera also were tested for their ability to amplify stimulation of
nucleoside incorporation by antibody (Table III) . The serum from a patient with
hereditary angioedema which was almost completely deficient in C2 plus C4
produced much less augmentation than NHS (maximum stimulation ratios of
8.2 and 139, respectively) . The serum from a patient with a total C1RD produced
stimulation of nucleoside uptake although it was less potent in this regard than
NHS (Table III) . This patient has Clq and C19 present in his serum and thus has
1-2% of the normal level of functional C1 (about 2,000 u/ml) . At 0.2% of GIRD
there was very little stimulation but at 0.5% there was a considerable stimulation
effect. This implies that free Cl,,, although highly inefficient, can stimulate
cellular incorporation of nucleoside in this system. Similarly, this concentrated
serum has some lytic activity in other systems .
Studies with Sera Deficient in C5 and C6 C Components .
￿
The ability of C5-
and C6-deficient sera to promote immunostimulation was examined in C5DHS,
C5DMS, and MRS (Fig. 3) . C5DHS promoted the increased uptake of
radioactive nucleoside as well as the NHS. The responses to C5DMS and NMS
were very similar. Judging from the results with MRS C6 also was nonessential
for C enhancement of immunostimulation.
The possibility that augmentation of nucleoside incorporation in the presence
of C5DHS, C5DMS, or MRS was due to C5 or C6 in the hNM was considered,
and we therefore determined the level of C5 and C6 in the hNM by functional
assays (Table IV) . The values for C5 and C6 in both hNm and NM were very low.
Thus it was unlikely that either C5 or C6 was being activated to a major extent
when cells interacted with antibody, even when unheated FCS was present. As
further evidence against the presence of C5 in hNM the addition of heat-inac-
tivated FCS (1 :1 dilution) did not restore any functional hemolytic units to the
C5DHS. Table IV also shows that heat inactivation of the FCS reduced the C4
level in hNM to an almost undetectable level. The C3 and C4 levels of the
C5DHS were normal, but the total hemolytic C level was zero.
Reconstitution Experiments with Normal Serum or Purified C Components.
Restoration of augmentation of immunostimulation was performed by the
addition of a small amount of normal serum to a C component-deficient serum in
the presence of antibody and by the addition of the purified C component itself.
For purposes of clarity, the restoration effects are presented for only the 1:2,000
dilution of antiserum, although restoration was observed at higher and lower
dilutions of antiserum . Thus augmentation of immunostimulation with C4D
could be restored with a small amount of NGPS in a dose-related fashion (Fig. 4) .
These amounts of NGPS did not similarly stimulate nucleoside incorporation of
identical conditions in hNM alone .
Purified guinea pig C3 restored the ability of (C3-C9)D to enhance immunos-
timulation. Fig. 5 shows the specificity of the restoration effect. C3 restored
immunostimulation to (C3-C9)D and not to C4D serum. The purified component
had little effect upon the immunostimulation properties of hNM or NGPS. In
experiments not shown we demonstrated a dose-response effect of C3 added to
(C3-C9)D. To insure that the restoration of (C3-C9)D was not a nonspecific effect
of purified C component we attempted to-restore the stimulation with C2 (human
and guinea pig) but failed (Fig. 5) .742
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FIG . 3 .
￿
Effects of C5 and C6 upon immunostimulation . Cells were cultured in hNM in the
presence ofsmall volumes ofPBS (clear columns), a 1 :2,000 dilution ofCR (hatched columns),
or a 1:2,000 dilution of AL (solid columns) . Small volumes of either PBS (PBS control column)
or other serums (0.2% final concentration vol/vol) were added to replicate sets of tubes.
C5DMSwasfrom SWR/J mice obtained from Dr. Philip D. Hoffsten (Department ofMedicine,
Washington University School of Medicine, St . Louis, Mo .) who has demonstrated (unpub-
lished observations) that SWR/J mice do not have C5 in their blood . The method of analysis
was lack of precipitation in double diffusion in agar gels ; the antiserum was obtained by
repeated intraperitoneal injections of serum from a B10 D2 New/J mouse (has C5) into a B10
D2 Old/J mouse (lacks C5) (15) .
TABLE IV
C Activity and C Component Levels in Mediums and Sera
C5DHS + hFCS
(1:1)
0
* Performed using Hyland Laboratories, Costa Mesa, Calif ., radial immunodiffusion plates .
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Since the addition of purified C3 to (C3-C9)D restored its immunostimulatory
activity, we attempted to look at the ability of purified guinea pig C3 to restore
cytotoxic activity (Fig . 6) . Here using a high concentration of the late (8 mo)
antiserum we were able to observe C-mediated cytotoxicity with NGPS (75%
reduction in counts per minute under the conditions used), no cytotoxicity with
(C3-C9)D by the addition of purified guinea pig C3 . It was obvious, then, that C
activation through C3 only was necessary for cytostimulation but cytotoxicity
required components acting later than C3 .
PBS Control NHS I C5DHS
20
10
PBS Control
s
"/ "rINN
CSD
1? 20
NM hNM NHS C5DHS
C3 (mg/100 ml)* 101-188 162
C4 (mg/100 ml)* 20-50 42
C4 (effective hemolytic U/ml) 2.9 0.7
C3 (effective hemolytic U/ml) 1.6 0.1 62,750 0
C6 (effective hemolytic U/ml) 1.4 0.9
Total hemolyticC (CH50 U) 175-250 0744
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FIG. 4.
￿
Restoration of immunostimulation with C4D by addition of NGPS: dose-response
effect. See legend to Fig. 3. Small volumesof either PBS (PBS control column) or C4D (C4D
column) (0.1%final concentration vol/vol) were addedto replicate sets oftubes.Finally, small
volumes of NGPS were added to some of the replicate sets of tubes.
FIG. 5.
￿
Restoration of immunostimulation with (C3-C9)D by addition of guinea pig C3 . See
the legend to Fig. 4 for the general description of conditions and symbols. The final
concentration of the guinea pig sera was 0.2%. Small volumes of highly purified guinea pig C
components, containing 10 functional units, were added to some replicate sets of tubes.
Human C2 also did not restore (C3-C9)D (data not shown).
Restoration was also studied with C2D. Purified human C2 restored augmenta-
tion of nucleoside incorporation into antibody-treated cells in the presence of
C2D (Fig. 7). No augmentation was seen when C2 was added to antibody-treated
cells in the absence of human sera or with NHS, ClRD, or C2,4D. Human or
guinea pig C3 did not restore C2D.
PBS Control NGPS CAD (C3-C9)D (C3-C9)D
r . -~ .. . . .m .
+C3 +C3 +C3 +C3 +C2
~O\\W. T. SHEARER, J. P . ATKINSON, M . M. FRANK, C. W. PARKER
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FIG. 6.
￿
C-mediated cytotoxicity : Attempted restoration of (C3-C9)D guinea pig serum with
purified guinea pig C3 . See Materials and Methods for description of procedure. Symbols are
the same as those for Fig. 4 except the CR and rabbit antiserum concentrations were higher
(1:10 final dilution) . Attempted restoration of (C3-C9)D was made with 100 U of highly
purified guinea pig C3 . Results are expressed as the mean of triplicate determinations ; the
lines represent the standard error . Incubation with ["'I ]UdR wasfrom 0-24 h before harvest-
ing and counting .
FIG. 7. Restoration of immunostimulation with C2D by addition of human C2 . See the
legend to Fig. 4forthe general description of conditions and symbols . Thefinal concentration
of guinea pig sera was 0.2%. Small volumes of highly purified human C components,
containing 10 functional units, were added to some replicate sets of tubes . Guinea pig C3 also
did not restore C2D (data not shown) .
As additional evidence for the activation of C in the immunostimulation
phenomenon we determined that there was a consumption ofC4 during the early
states (Table V) . There was both a time-dependent and antibody dose-depend-
ent consumption of guinea pig C4 during the first 12 h after exposure of cells to
antibody .
Fluorescence Microscopy Studies. Fig . 8 shows a specific deposition of
human C3 upon the membranesof cells treated with antiserum. In addition there
was redistribution and cap formation of the adherent C3 indicating an active746
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TABLE V
C4 Consumption During Immunostimulation
The results are the means of quadruplicate (PBS) and duplicate (CR and AL)
determinations of the functional C4 U/ml . Results are expressed as the mean t
standard error . There was some drop in C4 level with CR at the 1:200 dilution which
may be related to nonspecific activation by aggregated Ig. For differences between
experimental values and those of PBS controls at the same hour : *P < 0.05, $P
<0.01, §P <0.001, ~1P <0.05 from CR at the same dilution and hour .
cellular response to membrane perturbation . PBS control cells and cells treated
with control serum did not show these effects .
Discussion
At one time C was thought of as an agent which primarily mediated cell
membrane lysis leading to the destruction of cells . More recently it has been
recognized that C has other potent biological activities including effects on
phagocytosis (24), lysosomal enzyme and histamine release (25, 26), vascular
tone and permeability (27), chemotaxis (28), clot formation in some species (29),
and bone resorption (30) . The data presented in this report and elsewhere'
suggest that C may have yet another biological function, namely, that of
stimulation of cell growth and metabolism . It is not known whether the
stimulatory effect of C is due to sublethal damage and attempted cellular repair
or whether there is a more specific cell activation by C . Guttler demonstrated a
C-dependent twofold increase in phospholipid biosynthesis in HeLa cells
incubated with rabbit anti-HeLa IgG and guinea pig C (31) . He assumed that a
repair process was involved but there was no attempt to determine whether or not
late C components were needed for the response . While our studies do not clarify
the basis for the stimulation of phospholipid synthesis they do indicate that in
the stimulation of cell growth late C components (C5-C9) are not required,
suggesting that C effects on cell metabolism other than membrane lysis per se
need to be considered .
Although the basis for the augmentation of immunostimulation in association
with activation of the early C sequence is not presently clear, several explana-
tions are possible . Since a number of activated C components have proteolytic
activity, there may be a direct catalytic action of C on the cells . Proteolytic
enzymes have been shown to stimulate mitogenesis in cultured peripheral
lymphocytes and to enhance the response of these cells to phytohemagglutinin
(PHA) (32) . It has been suggested that proteolytic enzymes are normally
activated or released into the medium during stimulation by PHA (33-35). A
more general role for fibrinolytic enzymes in oncogenic transformation is
0.5h 4h 12h
PBS 100 1 1 104 1 7 98 1 3
CR 1:200 85 t 8* 81 t 12 69 f 3t
CR 1:2,000 105 1 5 98 t 9 89 1 2
AL 1 :200 68 t 14$ 66 t 0§ 48 t 2§, ~~
AL 1 :2,000 100 f 7 80 t 6* 65 t 7$, ~~W . T . SHEARER, J . P . ATKINSON, M . M . FRANK, C . W . PARKER
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F« . 8 .
￿
Human C3 fluorescence microscopy of cells treated with antibody and NHS. Cells
which were treated similarly except for substitution of CR for antibody did not show any
deposition of human C3 . x 500 .
suggested by the recent work of Unkeless et al . (36) . In attempting to explain
these stimulatory effects it seems likely that glycopeptides and glycoproteins are
being removed from the cell surface resulting in secondary effects on membrane
transport . In skeletal muscle and adipose tissue trypsin produces rapid and
dramatic changes in glucose transport (37) .748
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The possible relationship of our observations in tumor cells to the recently
postulated role ofC component C3 in B-cell activation needs to be considered .
Dukor and Hartman have proposed that B-cell activation takes place by mitogen
bridging of membrane receptors with concomitant interaction of activated C3
with the C3 membrane receptor (38) . Theofilopoulos et al . have demonstrated
binding sites for C3 and C3b on the human lymphoblastoid cell line (RAJI) ; the
binding of C3b to the cell activated the alternate C pathway and led to
membrane damage and cytolysis (39) . While these studies suggest that C or C
components play a crucial role in B-lymphocyte growth and function they do not
pertain to the question of whether or not other cells which presumably lack
well-defined receptors forC would undergo a similar response . Our studies with a
mouse fibroblastic cell line suggest that the activation effects of C are part of a
more general biological role of C in the promotion of cell growth during
inflammation . It is well known that fibroblastic growth and proliferation are
important in tissue responses to infection and trauma .
In addition to the collaborative effect of anti-L-cell antibody and C on
nucleoside incorporation, DNA synthesis, and cell growth in these cells, there are
less marked changes in these parameters in cells treated with antibody alone .
Since we excluded C merely by heat inactivation_, some heat-insensitive C
components may be interacting with antiserum and cells to produce immuno-
stimulation. However, since some of the C components needed for C-mediated
stimulation of cell growth are heat labile and there is residual stimulation with
component-deficient sera, this explanation is unlikely . In C-free systems
antibodies have been reported to activate potassium (40) and glycine (41)
transport so direct effects of antibody on plasma membrane function appear
possible .
Even though C is apparently not required for a response, when it is present the
minimal stimulatory concentration of antibody is reduced by several orders of
magnitude. The studies with sera deficient in selected C components indicate
that most of the effect of C, particularly that at low concentrations of antibody, is
exerted through the classical C pathway. Thus C4D was a poor stimulant of cell
growth even though it has alternate pathway activity . At high concentrations of
antibody, however, it did potentiate the response . These findings are similar to
those reported for sensitized sheep erythrocytes where the classical pathway is
required for C activation of lightly sensitized erythrocytes and the alternate
pathway can be activated when cells are heavily sensitized . This has been
analyzed in detail and found to proceed via the activation of a calcium-depend-
ent C1-like protein which in turn activates alternate pathway components (42,
43) .
The data presented in this paper clearly show that C has a dual action with
respectto target cell growth with stimulation at low antibody concentrations and
inhibition at high antibody concentrations . While the relationship of these
observations to the phenomenon of antibody enhancement of tumor cell growth
in vivo remains to be conclusively established, we have recently shown that
properly chosen doses of passively administered anti-L-cell antibodies signifi-
cantly stimulate L-cell growth in antibody-treated C3H mice deprived of T-cell
function (lethally initiated, thymectomized, and bone marrow reconstituted)W . T . SHEARER, J . P . ATKINSON, M . M . FRANK, C . W . PARKER
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(44) . Since the recipient animal's own immune response is already markedly
impaired it seems likely that the antibody is acting directly on tumor cell
metabolism rather than indirectly through specific inhibitory effects on the
host's immune system . Further experiments using C-depleted animals are in
progress and should help to define the role of C in the in vivo response .
Summary
When L cells were treated with anti-L-cell antibody in medium containing
heat-inactivated fetal calf serum, nucleoside uptake and cell growth were
stimulated . The response was markedly increased when fresh, unheated sera
from calves, guinea pigs, humans, mice, or rabbits were also present . The factors
in unheated serum responsible for the enhancement of immunostimulation were
studied. Using low concentrations of sera deficient in various complement (C)
components and low concentrations of antibody no augmentation of immuno-
stimulation was seen with Mr-deficient human serum, C2-deficient human
serum, C2,4-deficient human serum, C4-deficient guinea pig serum, C3-C9-de-
pleted guinea pig serum (by administration of cobra venom factor to animals),
but stimulation was observed with C5-deficient human serum, C5-deficient
mouse serum, and C6-deficient rabbit serum . When the concentration of anti-
serum was raised, however, augmentation was observed with C4-deficient guinea
pig serum . Thus, at low concentrations of antiserum enhancement appeared to
occur through the classical C pathway, whereas at high concentrations of anti-
body either the classical or alternate C pathways appeared to be involved . Stim-
ulation was specifically restored by purified C2 in C2-deficient serum and by C3
in C3-C9-deficient serum. Under the usual reaction conditions consumption of
guinea pig C component C4 could be demonstrated which provided direct
evidence for activation of the classical C pathway under conditions leading to
immunostimulation . By immunofluorescence, cells treated with antibody and
normal human serum had human C3 deposited at the cell surface.
Taken together these observations suggest that C activated through C3 by
either the classical or alternate pathways has the potential to enhance nucleoside
incorporation into DNA and cell growth of cells exposed to limiting amounts of
antibody . Although the mechanism of stimulation is unknown, it is likely to
involve a direct effect of C3 at the level of the cell membrane .
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